California eProcure #26-73021-000

RFI for Compounding Pharmacy Services (IM compound clozapine) for California State Hospitals

This opportunity seeks vendor input for providing intramuscular (IM) compound clozapine to California State Hospitals. - Government Buyer: - California Department of State Hospitals - Statewide hospital system covering Fresno, Los Angeles, Napa, San Bernardino, and San Luis Obispo counties - Products/Services Requested: - IM compound clozapine (no specific part number or quantity provided) - Compounding pharmacy services for IM compound clozapine - OEMs and Vendors: - No specific OEMs or vendors mentioned in the RFI - Unique/Notable Requirements: - Vendors are asked to provide information on their capabilities and cost structures - RFI is intended to establish a pool of potential bidders for a future solicitation - No mandatory pre-bid conference - Technical Details: - Focus is on compounding and supplying IM clozapine for patient care - Coverage across multiple counties in California

Description

The Department of State Hospitals (DSH) is issuing a Request for Information (RFI) to better understand the marketplace and potential bidder pool for contractors to provide intramuscular (IM) compound clozapine to support patient care across DSH's statewide hospital system. The DSH seeks input from qualified vendors regarding their capabilities and cost structures. This RFI aims to establish a bidder pool for a future solicitation. The event is open until September 30, 2026, and no pre-bid conference is scheduled.

View original listing